Metformin-associated lactic acidosis: Current perspectives on causes and risk

Metabolism: Clinical and Experimental
Ralph DeFronzoThomas A Bicsak

Abstract

Although metformin has become a drug of choice for the treatment of type 2 diabetes mellitus, some patients may not receive it owing to the risk of lactic acidosis. Metformin, along with other drugs in the biguanide class, increases plasma lactate levels in a plasma concentration-dependent manner by inhibiting mitochondrial respiration predominantly in the liver. Elevated plasma metformin concentrations (as occur in individuals with renal impairment) and a secondary event or condition that further disrupts lactate production or clearance (e.g., cirrhosis, sepsis, or hypoperfusion), are typically necessary to cause metformin-associated lactic acidosis (MALA). As these secondary events may be unpredictable and the mortality rate for MALA approaches 50%, metformin has been contraindicated in moderate and severe renal impairment since its FDA approval in patients with normal renal function or mild renal insufficiency to minimize the potential for toxic metformin levels and MALA. However, the reported incidence of lactic acidosis in clinical practice has proved to be very low (<10 cases per 100,000 patient-years). Several groups have suggested that current renal function cutoffs for metformin are too conservative, thus depriving a s...Continue Reading

References

Jun 1, 1992·Diabetes Care·C J Bailey
Aug 31, 1995·The New England Journal of Medicine·M StumvollJ E Gerich
Feb 29, 1996·The New England Journal of Medicine·C J Bailey, R C Turner
Nov 1, 1995·Journal of Clinical Pharmacology·N C SambolM G Cogan
May 1, 1997·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·D HeaneyB Junor
Jan 1, 1997·The American Journal of Medicine·M B Davidson, A L Peters
Jan 24, 1998·The New England Journal of Medicine·R I MisbinG A Fleming
Apr 29, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·N N ChanM D Feher
Jun 18, 1999·Diabetes Care·M StangD Butler-Jones
Jul 27, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·A M Emslie-SmithUNKNOWN DARTS/MEMO Collaboration
May 22, 2002·JAMA : the Journal of the American Medical Association·Cheryl HorlenRussell Rothman
Mar 20, 2003·Molecular Pharmacology·De-Sheng WangYuichi Sugiyama
Jan 30, 2004·Journal of Internal Medicine·A M E StadesJ B L Hoekstra
May 6, 2004·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·M-A von MachL Sacha Weilemann
Jul 15, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ulf PanzerGunter Wolf
Sep 8, 2005·Journal of Intensive Care Medicine·Pamela J Fall, Harold M Szerlip
Sep 9, 2005·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Ben HarveyAnton Mayer
Sep 24, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·R BrassøeC H Gravholt
Aug 16, 2006·Annals of Internal Medicine·Andrew S LeveyUNKNOWN Chronic Kidney Disease Epidemiology Collaboration
Jan 26, 2007·British Journal of Anaesthesia·M GaleaI White
Mar 3, 2007·Pharmacy World & Science : PWS·Waleed M Sweileh
Nov 2, 2007·Journal of Medical Case Reports·Joana SilvestreFatima Ceia
Mar 18, 2008·The Journal of Emergency Medicine·Damon M Dell'AglioBrent W Morgan
Mar 29, 2008·Journal of Clinical Pharmacology·Ying HongDonald E Mager
Apr 5, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Jaume AlmirallJosé-Miguel Gonzalez-Clemente
Apr 26, 2008·American Journal of Respiratory and Critical Care Medicine·Jaroslaw W ZmijewskiEdward Abraham
Jun 6, 2008·Diabetologia·C J BaileyJ H B Scarpello
Jun 24, 2008·The Journal of Emergency Medicine·Jeanmarie PerroneDavid Gaieski
Nov 28, 2008·Critical Care : the Official Journal of the Critical Care Forum·Nicolas PetersSébastien Gibot
Mar 27, 2009·The Kaohsiung Journal of Medical Sciences·Por-Wen YangHong-Da Lin
May 13, 2009·American Journal of Therapeutics·Anna Maria ArroyoLouise W Kao
Jun 3, 2009·Critical Care Medicine·Alexandre SeidowskyFrançois Fourrier
Sep 18, 2009·BMJ : British Medical Journal·Emma FitzgeraldAndrew Ball
Feb 23, 2010·Critical Care : the Official Journal of the Critical Care Forum·Alessandro ProttiLuciano Gattinoni

❮ Previous
Next ❯

Citations

Feb 3, 2016·Expert Opinion on Pharmacotherapy·André J Scheen
Jun 29, 2016·The Journal of Pharmacy and Pharmacology·Azusa FutatsugiYukio Kato
Oct 1, 2016·Diabetes, Obesity & Metabolism·Tahseen A ChowdhuryM Magdi Yaqoob
Oct 14, 2016·Diabetes, Obesity & Metabolism·Shaun S KumarRichard O Day
Jan 25, 2017·Current Diabetes Reports·Yoshihito Fujita, Nobuya Inagaki
Feb 9, 2017·Canadian Journal of Physiology and Pharmacology·Ravi NistalaLakshmi Pulakat
Feb 18, 2017·Nutrients·Fedra Luciano-MateoJorge Joven
Feb 6, 2017·Journal of Cellular Physiology·Soumaya Allouch, Shankar Munusamy
Apr 19, 2017·Diabetes, Obesity & Metabolism·Jean-Daniel LalauNicolas Wiernsperger
Sep 5, 2017·Heart Failure Reviews·William KuanMaya E Guglin
Nov 24, 2017·Npj Aging and Mechanisms of Disease·Irene AlfarasRafael de Cabo
Aug 18, 2017·Journal of Biological Rhythms·Emma HenrikssonKatja A Lamia
Dec 22, 2017·Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia·P K BipiM K Mohandas
Apr 25, 2018·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Su WoodDk Theo Raynor
Jan 28, 2018·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Joshua M GoldenbergMark D Pagel
Aug 3, 2018·Expert Opinion on Drug Safety·André J Scheen
Jun 14, 2017·Molecular and Cellular Biology·Tomoko Oyaizu-ToramaruYoji Andrew Minamishima
May 5, 2018·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Nur Liyana Mohammed YusofSiti Balkis Budin
Sep 18, 2018·Pharmacology Research & Perspectives·Ajith M DissanayakeChristopher J Hood
Nov 1, 2018·European Journal of Gastroenterology & Hepatology·Matt DriedgerCurtis L Cooper
Feb 3, 2018·BMJ Case Reports·Sajjad AliLavi Oud
Sep 30, 2018·Basic & Clinical Pharmacology & Toxicology·Tore Bjerregaard StageMaria C Kjellsson
Dec 26, 2018·International Journal of Molecular Sciences·Raphaëlle CorremansAnja Verhulst
Jun 20, 2019·Basic & Clinical Pharmacology & Toxicology·Alexandre StevensDavid Boels
Jun 5, 2019·Sports Medicine - Open·Grant TurnerJeff S Coombes
Jul 26, 2019·BioFactors·Alena PecinováTomáš Mráček
Aug 5, 2017·Diabetologia·Willy Marcos ValenciaHermes Florez
Feb 2, 2018·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Emilie TrinhJoanne M Bargman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Diabetic Medicine : a Journal of the British Diabetic Association
N N ChanM D Feher
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Jaume AlmirallJosé-Miguel Gonzalez-Clemente
© 2022 Meta ULC. All rights reserved